Primary fallopian tube cancer: Domestic data and up-to-date review

Taiwanese Journal of Obstetrics and Gynecology

Volumn 53, Issue 3, 2014, Pages 287-292

  Horng, Huann Cheng ^a,b   Teng, Sen Wen ^c,d   Huang, Ben Shian ^b   Sun, Hsu Dong ^b,e   Yen, Ming Shyen ^a,b   Wang, Peng Hui ^a,b,f   Tsui, Kuan Hao ^a,g,h,i   Wen, Kuo Chang ^a,b   Chen, Yi Jen ^a,b   Chuang, Chi Mu ^a,b   Chao, Hsiang Tai ^a,b   Chang, Wen Hsun ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CARDINAL TIEN HOSPITAL   (Taiwan)

^d FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^e FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^g NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^h KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ TAJEN UNIVERSITY   (Taiwan)

Author keywords

Outcome; Primary fallopian tube carcinoma; Prognosis; Treatment

Indexed keywords

CA 125 ANTIGEN; TUMOR MARKER;

ABDOMINAL PAIN; ADJUVANT CHEMOTHERAPY; ASYMPTOMATIC DISEASE; BLOOD; CANCER STAGING; CARCINOMA; DIAGNOSTIC IMAGING; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMAN; LYMPH NODE DISSECTION; SALPINGECTOMY; UTERINE HEMORRHAGE; VAGINA SMEAR;

ABDOMINAL PAIN; ASYMPTOMATIC DISEASES; CA-125 ANTIGEN; CARCINOMA; CHEMOTHERAPY, ADJUVANT; DIAGNOSTIC IMAGING; FALLOPIAN TUBE NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; SALPINGECTOMY; TUMOR MARKERS, BIOLOGICAL; UTERINE HEMORRHAGE; VAGINAL SMEARS;

EID: 84907534797     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2014.07.003     Document Type: Review

References (80)

1. Kalampokas E., Kalampokas T., Tourountous I. Primary fallopian tube carcinoma. Eur J Obstet Gynecol Reprod Biol 2013, 169:155-161.
2. Wang P.H., Liu R.S., Li Y.F., Ng H.T., Yuan C.C. Whole-body PET with (fluorine-18)-2-deoxyglucose for detecting recurrent primary serous peritoneal carcinoma: an initial report. Gynecol Oncol 2000, 77:44-47.
3. Ajithkumar T.V., Minimole A.L., John M.M., Ashokkumar O.S. Primary fallopian tube carcinoma. Obstet Gynecol Surv 2005, 60:247-252.
4. Pectasides D., Pectasides E., Papaxoinis G., Andreadis C., Papatsibas G., Fountzilas G., et al. Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients. Gynecol Oncol 2009, 115:97-101.
5. Xu Q., Xu N., Fang W., Zhao P., Mao C., Zheng Y., et al. Complete remission of platinum-refractory primary fallopian tube carcinoma with third-line gemcitabine plus cisplatin: a case report and review of literature. Oncol Lett 2013, 5:1601-1604.
6. Chao K.C., Chen Y.J., Juang C.M., Lau H.Y., Wen K.C., Sung P.L., et al. Prognosis for advanced-stage primary peritoneal serous papillary carcinoma and serous ovarian cancer in Taiwan. Taiwan J Obstet Gynecol 2013, 52:81-84.
7. Shih C.Y., Lai C.R., Huang C.Y., Twu N.F., Chao K.C., Wang P.H. Achallenge in the management of a patient with ovarian cancer associated with extensive endometriosis. Taiwan J Obstet Gynecol 2012, 51:324-325.
8. Rosen A.C., Sevelda P., Klein M., Graf A.H., Lahousen M., Reiner A., et al. Acomparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. Br J Cancer 1994, 69:577-579.
9. Wang P.H., Yuan C.C., Chao H.T. Surgico-pathological stage I primary fallopian tube adenocarcinoma. Int J Gynaecol Obstet 1998, 63:73-74.
10. Wang P.H., Yuan C.C., Chao H.T., Juang C.M., Ng H.T. Prognosis of primary fallopian tube adenocarcinoma: report of 25 patients. Eur J Gynaecol Oncol 1998, 19:571-574.
11. Lau H.Y., Chen Y.J., Yen M.S., Chen R.F., Yeh S.O., Twu N.F. Primary fallopian tube carcinoma: a clinicopathologic analysis and literature review. JChin Med Assoc 2013, 76:583-587.
12. Ou Y.C., Huang H.Y., Huang C.C., Changchien C.C., Tseng C.W., Lin H. Primary fallopian tube carcinoma: clinicopathological analysis of 12 cases. Taiwan J Obstet Gynecol 2011, 50:141-144.
13. Wang P.H., Yuan C.C., Chao H.T., Yen M.S., Ng H.T. Outcome of advanced primary fallopian tube adenocarcinoma. Zhonghua Yi Xue Za Zhi (Taipei) 1999, 62:782-786.
14. Huang B.S., Chao K.C., Chang W.H., Wang P.H. Primary fallopian tube carcinoma. Taiwan J Obstet Gynecol 2012, 51:143-144.
15. Lin C.K., Chang C.C., Pan S.H., Yu M.H. Primary fallopian tube cancer may mimic endometrial malignancy. Taiwan J Obstet Gynecol 2008, 47:218-219.
16. Su Y.N., Cheng W.F., Chen C.A., Lin T.Y., Hsieh F.J., Cheng S.P., et al. Pregnancy with primary tubal placental site trophoblastic tumor-a case report and literature review. Gynecol Oncol 1999, 73:322-325.
17. Wang P.H., Lee R.C., Chao K.C., Chao H.T., Yuan C.C., Ng H.T. Preoperative diagnosis of primary fallopian tube carcinoma by magnetic resonance imaging: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1998, 61:755-759.
18. Chiou Y.K., Su I.J., Chen C.A., Hsieh C.Y. Malignant mixed müllerian tumor of the fallopian tube. JFormos Med Assoc 1991, 90:793-795.
19. Chang H.C., Hsueh S., Soong Y.K. Malignant mixed müllerian tumor of the fallopian tube. Case report and review of the literature. Changgeng Yi Xue Za Zhi 1991, 14:259-263.
20. Hseih C.S., Cheng G.F., Liu Y.G., Han C.P., Chen S.S. Benign cystic teratoma of unilateral fallopian tube associated with intrauterine pregnancy: a case report. Zhonghua Yi Xue Za Zhi (Taipei) 1998, 61:239-242.
21. Chao T.J., Chao J., Kuan L.J., Li Y.T., Kuo T.C., Chang Y.C., et al. Mature solid teratoma of the fallopian tube associated with uterine leiomyomas. JChin Med Assoc 2008, 71:425-427.
22. Yang C.C., Wen K.C., Chen P., Wang P.H. Primary leiomyoma of the fallopian tube: preoperative ultrasound findings. JChin Med Assoc 2007, 70:80-83.
23. Wen K.C., Yang C.C., Wang P.H. Primary fallopian tube leiomyoma managed by laparoscopy. JMinim Invasive Gynecol 2005, 12:193.
24. Rose P.G., Piver M.S., Tsukada Y. Fallopian tube cancer. The Roswell Park experience. Cancer 1990, 66:2661-2667.
25. Barakat R.R., Rubin S.C., Saigo P.E., Lewis J.L., Jones W.B., Curtin J.P. Second-look laparotomy in carcinoma of the fallopian tube. Obstet Gynecol 1993, 82:748-751.
26. Hellström A.C., Silfverswärd C., Nilsson B., Pettersson F. Carcinoma of the fallopian tube. A clinical and histopathologic review. The Radiumhemmet series. Int J Gynecol Cancer 1994, 4:395-400.
27. Pfeiffer P., Mogensen H., Amtrup F., Honore E. Primary carcinoma of the fallopian tube. Acta Oncol 1989, 28:7-11.
28. Rosen A.C., Reiner A., Klein M., Lahousen M., Graf A.H., Vavra N., et al. Prognostic factors in primary fallopian tube carcinoma. Gynecol Oncol 1994, 53:307-313.
29. Zheng W., Sung C.J., Cao P., Zhang Z.F., Cai R., Godwin T.A., et al. Early occurrence and prognostic significance of p53 alteration in primary carcinoma of the fallopian tube. Gynecol Oncol 1997, 64:38-48.
30. Vaughan M.M., Evans B.D., Baranyai J., Weitzer M.J. Survival of patients with primary fallopian tube carcinoma. Int J Gynecol Cancer 1998, 8:16-22.
31. Wolfson A.H., Tralins K.S., Greven K.M., Kim R.Y., Corn B.W., Kuettel M.R., et al. Adenocarcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 72 patients. Int J Radiat Oncol Biol Phys 1998, 40:71-76.
32. Rosen A.C., Klein M., Hafner E., Lahousen M., Graf A.H., Reiner A., et al. Management and prognosis of primary fallopian tube carcinoma. Gynecol Obstet Invest 1999, 47:45-51.
33. Klein M., Rosen A.C., Lahousen M., Graf A.H., Rainer A. Lymphadenectomy in primary carcinoma of the fallopian tube. Cancer Lett 1999, 147:63-66.
34. Alvarado-Cabrero I., Young R.H., Vamvakas E.C., Scully R.E. Carcinoma of the fallopian tube: a clinicopathological study of 105 cases with observations on staging and prognostic factor. Gynecol Oncol 1999, 72:367-379.
35. Rosen A.C., Ausch C., Klein M., Graf A.H., Metzenbauer M., Philipp K., et al. p53 expression in fallopian tube carcinomas. Cancer Lett 2000, 156:1-7.
36. Klein M., Rosen A.C., Lahousen M., Graf A.H., Rainer A. The relevance of adjuvant therapy in primary carcinoma of the fallopian tube, stages I and II: irradiation vs. chemotherapy. Int J Radiat Oncol Biol Phys 2000, 48:1427-1431.
37. Hefler L.A., Rosen A.C., Graf A.H., Lahousen M., Klein M., Leodolter S., et al. The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter study. Cancer 2000, 89:1555-1560.
38. Baekelandt M., Nesbakken A.J., Kristensen G.B., Trope C.G., Abeler V.M. Carcinoma of the fallopian tube: clinicopathologic study of 151 patients treated at the Norwegian Radium Hospital. Cancer 2000, 89:2076-2084.
39. Obermair A., Taylor K.H., Janda M., Nicklin J.L., Crandon A.J., Perrin L. Primary fallopian tube carcinoma: the Queensland experience. Int J Gynecol Cancer 2001, 11:69-72.
40. Gadducci A., Landoni F., Sartori E., Maggino T., Zola P., Gabriele A., et al. Analysis of treatment failures and survival of patients with fallopian tube carcinoma: a cooperation task force (CTF) study. Gynecol Oncol 2001, 81:150-159.
41. Klein M., Graf A.H., Rosen A., Lahousen M., Hacker G.W. Tumor progression, histologic grading and DNA-ploidy as predictive factors of lymphogenous metastasis in primary carcinoma of the fallopian tube. Cancer Lett 2002, 17:209-214.
42. Kosary C., Trimble E.L. Treatment and survival for women with Fallopian tube carcinoma: a population-based study. Gynecol Oncol 2002, 86:190-191.
43. Heintz A.P., Odicino F., Maisonneuve P., Beller U., Benedet J.L., Creasman W.T., et al. Carcinoma of the fallopian tube. Int J Gynaecol Obstet 2003, 83:19-33.
44. Riska A., Alfthan H., Finne P., Jalkanen J., Sorvari T., Stenman U.H. Preoperative serum hCGbeta as a prognostic marker in primary fallopian tube carcinoma. Tumor Biol 2006, 27:43-49.
45. Moore K.N., Moxley K.M., Fader A.N., Axtell A.E., Rocconi R.P., Abaid L.N., et al. Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary. Gynecol Oncol 2007, 107:398-403.
46. Wethington S.L., Herzog T.J., Seshan V.E., Bansal N., Schiff P.B., Burke W.M., et al. Improved survival for fallopian tube cancer: a comparison of clinical characteristics and outcome for primary fallopian tube and ovarian cancer. Cancer 2008, 113:3298-3306.
47. Shamshirsaz A.A., Buekers T., Degeest K., Bender D., Zamba G., Goodheart M.J. Asingle-institution evaluation of factors important in fallopian tube carcinoma recurrence and survival. Int J Gynecol Cancer 2011, 21:1232-1240.
48. Alvarado-Cabrero I., Stolnicu S., Kiyokawa T., Yamada K., Nikaido T., Santiago-Payan H. Carcinoma of the fallopian tube: results of a multi-institutional retrospective analysis of 127 patients with evaluation of staging and prognostic factors. Ann Diagn Pathol 2013, 17:159-164.
49. Su W.H., Tsou T.S., Chen C.S., Ho T.Y., Lee W.L., Yu Y.Y., et al. Are we satisfied with the tools for the diagnosis of gonococcal infection in females?. JChin Med Assoc 2011, 74:430-434.
50. Su W.H., Tsou T.S., Chen C.S., Ho T.Y., Lee W.L., Yu Y.Y., et al. Diagnosis of Chlamydia infection in females. Taiwan J Obstet Gynecol 2011, 50:261-267.
51. Pusiol T., Piscioli F., Morelli L., Parolari A.M., Licci S. Cervicovaginal smears in the diagnosis of asymptomatic primary fallopian tube carcinoma. Cytopathology 2009, 20:409-411.
52. Gupta D., Balsara G. Extrauterine malignancies. Role of Pap smears in diagnosis and management. Acta Cytol 1999, 43:806-813.
53. Pectasides D., Pectasides E., Economopoulos T. Fallopian tube carcinoma: a review. Oncologist 2006, 11:902-912.
54. Rezvani M., Shaaban A.M. Fallopian tube disease in the nonpregnant patient. Radiographics 2011, 31:527-548.
55. Shaaban A.M., Rezvani M. Imaging of primary fallopian tube carcinoma. Abdom Imaging 2013, 38:608-618.
56. Slanetz P.J., Whitman G.J., Halpern E.F., Hall D.A., McCarthy K.A., Simeone J.F. Imaging of fallopian tube tumors. AJR Am J Roentgenol 1997, 169:1321-1324.
57. Kawakami S., Togashi K., Kimura I., Nakano Y., Koshiyama M., Takakura K., et al. Primary malignant tumor of the fallopian tube: appearance at CT and MR imaging. Radiology 1993, 186:503-508.
58. Haratz-Rubinstein N., Russell B., Gal D. Sonographic diagnosis of Fallopian tube carcinoma. Ultrasound Obstet Gynecol 2004, 24:86-88.
59. Hu C.Y., Taymor M.L., Hertig A.T. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1950, 59:58-67.
60. Sedlis A. Primary carcinoma of the fallopian tube. Obstet Gynecol Surv 1961, 16:209-226.
61. Sedlis A. Carcinoma of the fallopian tube. Surg Clin North Am 1978, 58:121-129.
62. Wu H.S., Wang P.H., Yeh J.Y., Chen Y.J., Yen M.S., Tasi Y.J., et al. Serum cytokeratin-19 fragment (Cyfra 21-1) is a prognostic indicator for epithelial ovarian cancer. Taiwan J Obstet Gynecol 2014, 53:30-34.
63. Chang Y.W., Chao K.C., Sung P.L., Li W.H., Wang P.H. Fertility preservation with treatment of endodermal sinus tumor of the ovary. JChin Med Assoc 2013, 76:112-114.
64. Wang P.H., Shyong W.Y., Li Y.F., Lee H.H., Tsai W.Y., Chao H.T., et al. BRCA1 mutations in Taiwanese with epithelial ovarian carcinoma and sporadic primary serious peritoneal carcinoma. Jpn J Clin Oncol 2000, 30:343-348.
65. Wang P.H., Yuan C.C., Juang C.M., Lai C.R., Yen M.S., Chao H.T., et al. Primary epithelial ovarian carcinoma in Taiwanese women. Eur J Gynecol Oncol 2001, 22:57-60.
66. Tamimi H.K., Figge D.C. Adenocarcinoma of the uterine tube: potential for lymph node metastases. Am J Obstet Gynecol 1981, 141:132-137.
67. Koo Y.J., Kwon Y.S., Lim K.T., Lee K.H., Shim J.U., Mok J.E. Para-aortic lymphadenectomy for primary fallopian tube cancer. Int J Gynaecol Obstet 2011, 112:18-20.
68. Deffieux X., Morice P., Thoury A., Camatte S., Duvillard P., Castaigne D. Anatomy of pelvic and para-aortic nodal spread in patients with primary fallopian tube carcinoma. JAm Coll Surg 2005, 200:45-48.
69. Wang P.H., Lee W.L., Juang C.M., Yang Y.H., Lo W.H., Lai C.R., et al. Altered mRNA expressions of sialyltransferases in ovarian cancers. Gynecol Oncol 2005, 99:631-639.
70. Wang P.H., Chang C. Androgens and ovarian cancer. Eur J Gynecol Oncol 2004, 25:157-163.
71. Huang B.S., Sun H.D., Hsu Y.M., Chang W.H., Horng H.C., Yen M.S., et al. Clinical presentation and outcome of adult-type granulosa cell tumors: a retrospective study of 30 patients in a single institute. JChin Med Assoc 2014, 77:21-25.
72. Wang P.H., Yuan C.C., Shyong W.Y., Chiang S.C., Chao J.Y., Yen M.S., et al. Optimal debulking surgery seems to be an independent prognostic factor in patients with FIGO IIIC primary epithelial ovarian carcinoma. JChin Med Assoc 2000, 63:220-225.
73. Horng H.C., Yuan C.C., Lai C.R., Wang P.H. Presumed stage IA primary epithelial ovarian carcinoma: the role of complete staging surgery. Eur J Gynaecol Oncol 2007, 28:43-44.
74. Katsumata N., Yasuda M., Isonishi S., Takahashi F., Michimae H., Kimura E., et al. Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial. Lancet Oncol 2013, 14:1020-1026. Japanese Gynecologic Oncology Group.
75. Bookman M.A., Brady M.F., McGuire W.P., Harper P.G., Alberts D.S., Friedlander M., et al. Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a phase III Trial of the Gynecologic Cancer Intergroup. JClin Oncol 2009, 27:1419-1425.
76. Jaaback K., Johnson N., Lawrie T.A. Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer. Cochrane Database Syst Rev 2011, 11:CD005340.
77. Katsumata N., Yasuda M., Takahashi F., Isonishi S., Jobo T., Aoki D., et al. Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial. Lancet 2009, 374:1331-1338.
78. Yen M.S., Ng H.T., Wang P.H. Adelicate surgical method for cancer treatment is welcome. Taiwan J Obstet Gynecol 2012, 51:329-330.
79. Yen M.S., Ng H.T., Wang P.H. Teamwork is needed for better care. Taiwan J Obstet Gynecol 2013, 52:159-160.
80. Horng H.C., Teng S.W., Lai C.R., Chang W.H., Chang Y.H., Yen M.S., et al. Prognostic factors of primary fallopian tube cancer in a single institute in Taiwan. Int J Gynaecol Obstet 2014 Jun 19, pii: S0020-7292(14)00306-3. http://dx.doi.org/10.1016/j.ijgo.2014.04.018.